IBT Staff Reporter

97261-97290 (out of 154943)

Lehman sues Nomura to void $760 million claims

Lehman Brothers Holdings Inc sued Nomura Holdings Inc on Friday, saying the Japanese bank is not entitled to recover $760 million it claims, and instead owes it tens of millions of dollars.

Ford to recall 33,256 vehicles to fix seat fault

Ford Motor Co will recall 33,256 of its 2010 model year cars and SUVs to replace potentially faulty front seat recliner mechanisms that could lead to injuries in an accident, according to a notice filed with U.S. safety regulators.

Durable goods orders ex-transport, home sales up

New orders for durable U.S. manufactured goods excluding transportation posted the largest gain in over two years in March while home sales hit an eight-month high, hinting at a pick-up in the pace of growth.

Army kills Raytheon-Lockheed arms program

The U.S. Army has canceled a joint Raytheon Co-Lockheed Martin Corp precision attack missile program 90 percent of the way through a six-year, $1 billion-plus development phase, Raytheon said Friday.

Goldman director in focus on Berkshire deal: report

A Goldman Sachs Inc director told hedge fund founder Raj Rajaratnam about Berkshire Hathaway's $5 billion investment in Goldman before the deal became public, the Wall Street Journal reported on Friday, citing a person close to the situation.

Treasury seeks advice on reducing coupon sizes

The U.S. Treasury, signaling that its debt issuance has likely peaked, on Friday asked its primary bond dealers for advice on how best to reduce coupon sizes as the government's fiscal outlook improves.

Flu vaccine under investigation after flu jab scare

Drug regulators are immediately investigating the flu vaccine used for children to check for its safety following the announcement by Australia's chief medical officer to halt immunization for children under five years of age.

Johnson Controls raises outlook

Johnson Controls Inc raised its fiscal-year earnings forecast on Friday after posting a better-than-expected quarterly profit amid increased auto production, sending its shares 2 percent higher.

Wall St flat as rally fades, Greece weighs

U.S. stocks were little changed on Friday as a morning rally lost steam and worries about the long-term outlook for Greece's shaky finances curbed investors' appetite for risk.

Greece presses aid button, markets still wary

Debt-stricken Greece appealed to its European partners and the IMF for emergency loans on Friday, yielding to overwhelming market pressure to set in motion the first financial rescue of a member of the euro zone.

Novo's Victoza beats Merck drug in diabetes study

(Reuters) - Novo Nordisk's new diabetes drug Victoza proved more effective than Merck & Co's Januvia in a head-to-head study, boosting prospects for a product that has got off to a strong start in key markets.

Pages